Showing 8,001 - 8,020 results of 18,406 for search 'significantly ((less decrease) OR (((((teer decrease) OR (mean decrease))) OR (a decrease))))', query time: 0.78s Refine Results
  1. 8001

    Table 1_Non-chemotherapy drugs inducing agranulocytosis: a disproportionality analysis based on the FAERS database.xlsx by Shanshan Wu (348762)

    Published 2025
    “…Notably, NCDIA-associated mortality rates showed a significant decrease from 11.91% (2004–2010) to 7.28% (2021–2024) (P < 0.001).…”
  2. 8002

    Data Sheet 2_Toxocariasis in children: seroprevalence after 15 years in a major city in Brazil.docx by Viviane dos Santos Vaccaro Lima (22644209)

    Published 2025
    “…The findings presented no significant difference (p = 0.879) when compared to those of a previous 2008 serosurvey, with 28/252 (11.1%; 95% CI: 7.8%–15.6%) seropositive children.…”
  3. 8003

    Image 1_Non-chemotherapy drugs inducing agranulocytosis: a disproportionality analysis based on the FAERS database.pdf by Shanshan Wu (348762)

    Published 2025
    “…Notably, NCDIA-associated mortality rates showed a significant decrease from 11.91% (2004–2010) to 7.28% (2021–2024) (P < 0.001).…”
  4. 8004

    Data Sheet 1_Toxocariasis in children: seroprevalence after 15 years in a major city in Brazil.pdf by Viviane dos Santos Vaccaro Lima (22644209)

    Published 2025
    “…The findings presented no significant difference (p = 0.879) when compared to those of a previous 2008 serosurvey, with 28/252 (11.1%; 95% CI: 7.8%–15.6%) seropositive children.…”
  5. 8005

    [A] Histopathological images of pancreas, liver, kidney, and heart tissues from the studied rat groups, stained with H&E. by Mohamed Lotfy (18599184)

    Published 2025
    “…The values are presented as mean ± SEM. <sup>#</sup> Indicates significant difference (P ≤ 0.05) between the untreated diabetic group and the control group. * Indicates a significant difference (P ≤ 0.05) between the C. lancifolius-treated or crocin-treated diabetic group and the untreated diabetic group. …”
  6. 8006

    AI-guided EMS for chronic musculoskeletal pain: subgroup-level outcomes from a digital health platform by Maja Green (8462307)

    Published 2025
    “…</p> <p>Across ~185,000 sessions, users reported significant pain reduction. Mean pain decreased by 2.4 points (<i>p</i> < 0.001), exceeding 30% improvement, with benefits sustained at 12 and 24 months. …”
  7. 8007

    Data Sheet 1_Preclinical evidence for luteolin in ulcerative colitis: a meta-analysis and systematic review.docx by Yiyi Feng (12530035)

    Published 2025
    “…The search, covering data up to March 2025, yielded 19 eligible studies involving a total of 327 animal subjects. The outcomes were analyzed using the standard mean difference with a 95% confidence interval in R (4.3.3) software.…”
  8. 8008

    Data Sheet 1_Fatty infiltration and cross-sectional area as indicators of muscle mass in osteoporosis: a meta-regression study.pdf by Genwen Sun (22678739)

    Published 2025
    “…Three-level meta-regression models were implemented to examine the influence of study-level moderators, including age, sex, measurement level and comparison category.</p>Results<p>A significant decrease in CSA was observed only in osteoporotic patients compared with controls, and multiple muscle groups were evaluated. …”
  9. 8009

    Data Sheet 1_Efficacy and safety of reduning injection for severe pneumonia: a systematic review and meta-analysis.docx by Yan Wang (15435)

    Published 2025
    “…Objectives<p>Reduning (RDN) injection is a traditional Chinese medicine (TCM) extract injection commonly used as an adjunct therapy for severe pneumonia (SP) in clinical practice in China; however, further validation is required. …”
  10. 8010

    Long-term changes in ABG parameters retrospectively tracked from the initiation of LTOT in the CRF group. by Kazuma Nagata (3400058)

    Published 2025
    “…<p>From five years prior to the initiation of LTOT, a decrease in PaO<sub>2</sub> and PaCO<sub>2</sub>, accompanied by an increase in A-aDO<sub>2</sub>, was observed. …”
  11. 8011

    Image 1_Immunosuppressants in dermatology on vaccine immunogenicity: a prospective cohort study of pemphigus patients in the pandemic.tif by Kun-Lin Lu (7256960)

    Published 2024
    “…Intriguingly, we found that daily dosages of 100 mg or more of azathioprine were linked to significantly decreased anti-viral T-cell responses induced by the vaccination (mean of fold change [SD]; higher azathioprine dosage = 0.70 [0.61] folds vs. lower azathioprine dosage = 2.11 [1.03] folds; p = 0.044).…”
  12. 8012

    Image 2_Immunosuppressants in dermatology on vaccine immunogenicity: a prospective cohort study of pemphigus patients in the pandemic.tif by Kun-Lin Lu (7256960)

    Published 2024
    “…Intriguingly, we found that daily dosages of 100 mg or more of azathioprine were linked to significantly decreased anti-viral T-cell responses induced by the vaccination (mean of fold change [SD]; higher azathioprine dosage = 0.70 [0.61] folds vs. lower azathioprine dosage = 2.11 [1.03] folds; p = 0.044).…”
  13. 8013

    Statistical summaries. by Magdalena Kunat-Budzyńska (20565222)

    Published 2025
    “…This may indicate that infection causes a decrease in the effectiveness of primarily antioxidant mechanisms, whereas immune mechanisms are still activated during infection. …”
  14. 8014

    Table 1_Influence of intraoperative electromyographic changes and surgical extent on post-thyroidectomy esophageal motility: a prospective cohort study.docx by Mehmet Gunay (14384565)

    Published 2025
    “…Postoperative upper esophageal sphincter resting pressure (UESRP) significantly decreased from a median of 181 mmHg (range: 12–407 mmHg) to 109 mmHg (range: 8.6–407 mmHg), postoperatively (p=0.03). …”
  15. 8015

    Enteropathogen detection and fCal levels. by Muhammad Rehan (406524)

    Published 2025
    “…<div><p>Diarrheal disease is a leading cause of death among young children globally. …”
  16. 8016

    Roadbed construction process. by Yunke Liu (4839084)

    Published 2024
    “…The results show that the cement-phosphogypsum-red clay unconfined compressive strength decreases with the increase of the number of wet and dry cycles, with a larger decay in the first three times and leveling off thereafter. …”
  17. 8017

    Mixing ratios. by Yunke Liu (4839084)

    Published 2024
    “…The results show that the cement-phosphogypsum-red clay unconfined compressive strength decreases with the increase of the number of wet and dry cycles, with a larger decay in the first three times and leveling off thereafter. …”
  18. 8018

    Basic parameters of phosphogypsum. by Yunke Liu (4839084)

    Published 2024
    “…The results show that the cement-phosphogypsum-red clay unconfined compressive strength decreases with the increase of the number of wet and dry cycles, with a larger decay in the first three times and leveling off thereafter. …”
  19. 8019

    Chemical composition of phosphogypsum. by Yunke Liu (4839084)

    Published 2024
    “…The results show that the cement-phosphogypsum-red clay unconfined compressive strength decreases with the increase of the number of wet and dry cycles, with a larger decay in the first three times and leveling off thereafter. …”
  20. 8020

    Basic parameters of cement. by Yunke Liu (4839084)

    Published 2024
    “…The results show that the cement-phosphogypsum-red clay unconfined compressive strength decreases with the increase of the number of wet and dry cycles, with a larger decay in the first three times and leveling off thereafter. …”